BRÈVE publiée le 18/11/2025 à 15:35, il y a 5 mois 15 jours The Vanguard Group, Inc.: Disclosure on Avadel Pharmaceuticals plc Form 8.3 Disclosure Irish Takeover Panel Vanguard Group Avadel Pharmaceuticals
BRÈVE publiée le 18/11/2025 à 15:35, il y a 5 mois 15 jours The Vanguard Group, Inc. : Informations sur Avadel Pharmaceuticals plc Groupe Vanguard Divulgation Formulaire 8.3 Avadel Pharmaceuticals Panel Irlandais Des OPA
COMMUNIQUÉ DE PRESSE publié le 18/11/2025 à 15:34, il y a 5 mois 15 jours Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated The Vanguard Group, Inc. discloses 10.65% ownership in Qualcomm Incorporated with recent dealings in USD 0.0001 common stock The Vanguard Group Dealings Ownership Stock Qualcomm Incorporated
BRÈVE publiée le 18/11/2025 à 15:33, il y a 5 mois 15 jours The Vanguard Group Files Form 8.3 on Mural Oncology plc Holdings Form 8.3 Vanguard Group Shareholding Irish Takeover Rules Mural Oncology
BRÈVE publiée le 18/11/2025 à 15:33, il y a 5 mois 15 jours Le groupe Vanguard dépose le formulaire 8.3 concernant Mural Oncology plc Holdings. Actionnariat Groupe Vanguard Formulaire 8.3 Oncologie Murale Règles Irlandaises En Matière De Rachat D'entreprises
COMMUNIQUÉ DE PRESSE publié le 18/11/2025 à 15:33, il y a 5 mois 15 jours Form 8.3 - The Vanguard Group, Inc.: Just Group plc The Vanguard Group, Inc. discloses a 5.37% interest in Just Group plc's 10p ordinary securities. Details in compliance with the Takeover Code Securities Disclosure Takeover Code Vanguard Group Just Group Plc
COMMUNIQUÉ DE PRESSE publié le 18/11/2025 à 15:32, il y a 5 mois 15 jours Form 8.3 - The Vanguard Group, Inc.: Wood Group (John) plc The Vanguard Group, Inc. discloses a 0.56% stake in Wood Group (John) plc on 17 Nov 2025. Details in Form 8.3 show sale of 3,862,306 securities at 0.22 GBP per unit Form 8.3 The Vanguard Group Stake Disclosure Securities Sale Wood Group (John) PLC
COMMUNIQUÉ DE PRESSE publié le 18/11/2025 à 15:30, il y a 5 mois 15 jours Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc The Vanguard Group, Inc. discloses a 5.68% ownership in Avadel Pharmaceuticals plc, with 5,527,806 US$0.01 ordinary shares held. Purchase of 665 shares at 23.02 USD per unit on 17 Nov 2025 The Vanguard Group Stock Purchase Ownership Disclosure Financial Disclosure Avadel Pharmaceuticals Plc
COMMUNIQUÉ DE PRESSE publié le 18/11/2025 à 15:28, il y a 5 mois 15 jours Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc The Vanguard Group, Inc. discloses 1.67% stake in Mural Oncology plc under Form 8.3 with relevant securities owned. No other parties disclosed Form 8.3 Relevant Securities Vanguard Group Stake Disclosure Mural Oncology Plc
BRÈVE publiée le 17/11/2025 à 18:34, il y a 5 mois 15 jours The Vanguard Group's Disclosure on Qualcomm Form 8.3 The Vanguard Group Securities Disclosure Stock Positions Qualcomm
Publié le 30/04/2026 à 21:21, il y a 2 jours 18 heures CP -Mise à disposition du rapport financier annuel 2025
Publié le 30/04/2026 à 20:00, il y a 2 jours 19 heures AMA Corp PLC : FY 2025 Earnings & Q1 2026 Revenue
Publié le 30/04/2026 à 20:00, il y a 2 jours 19 heures AMA Corp PLC : Résultats 2025 & Chiffre d'affaires du 1er trimestre 2026
Publié le 30/04/2026 à 19:16, il y a 2 jours 20 heures AXA announces the results of its Shareholders' Meeting
Publié le 30/04/2026 à 19:16, il y a 2 jours 20 heures AXA annonce les résultats de son Assemblée Générale
Publié le 02/05/2026 à 21:00, il y a 18 heures 49 minutes GECC Subsidiary Provides Update on its Lawsuit for Damages Against the Lender of the Atmosphere Project
Publié le 02/05/2026 à 01:30, il y a 1 jour 14 heures Uraniumx Reports Strong Financial Position Ahead of Spring Drill Program
Publié le 02/05/2026 à 00:50, il y a 1 jour 14 heures CoTec Announces Annual Stock Option, Restricted Share Unit And Deferred Share Unit Grants
Publié le 02/05/2026 à 00:00, il y a 1 jour 15 heures Redwood AI Announces Enhanced AI Models, Increasing Evaluated Chemical Reactions Following Preliminary Results from UBC Collaboration
Publié le 02/05/2026 à 00:00, il y a 1 jour 15 heures Onco-Innovations Expands Manufacturing Scale-Up of Its PNKP Inhibitor Technology with Dalton Pharma Services, Advancing Multi-Kilogram Non-GMP Synthesis to Support IND-Enabling Studies
Publié le 03/05/2026 à 04:45, il y a 11 heures 4 minutes GWM Unveils World-Class Safety & Testing Facilities: Safety Built on Data, Not Hype
Publié le 02/05/2026 à 15:35, il y a 1 jour Ecuador's banana sector renews labor agreement, with jobs meeting global standards
Publié le 01/05/2026 à 19:23, il y a 1 jour 20 heures Fuller, Smith & Turner PLC: Transaction in own shares
